A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration

Acta ophthalmologica

Volumn 92, Issue 8, 2014, Pages e691-e692

  van Hagen, P Martin ^a   Baarsma, G Seerp ^a   van Bilsen, Christel E ^a   Kuijpers, Robert W ^a   van Laar, Jan A ^a   van der Ent, Marianne ^a   van Daele, Paul L ^a   Veeger, Nico J ^a   Vingerling, Johannes R ^a   Missotten, Tom O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; INFLIXIMAB; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; CLINICAL TRIAL; CONTRAST SENSITIVITY; DRUG EFFECTS; EXUDATE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY; WET MACULAR DEGENERATION;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CONTRAST SENSITIVITY; EXUDATES AND TRANSUDATES; HUMANS; OPHTHALMIC SOLUTIONS; TUMOR NECROSIS FACTOR-ALPHA; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 85027955715     PISSN: None     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12471     Document Type: Article

References (0)